BioMarin Pharmaceutical(BMRN) - 2023 Q4 - Annual Results

Exhibit 99.1 BioMarin Reports Record Financial Results for the Fourth Quarter and Full-year 2023 and Provides Financial Guidance for 2024 SAN RAFAEL, Calif., February 22, 2024 – BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced financial results for the fourth quarter and full year ended December 31, 2023. 1 | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |----------------------------------------------|-------|----------------|-------------|------------------------------------- ...